Rationale for the potential use of recombinant activated factor vii in severe post-partum hemorrhage

HIGHLIGHTS

• What: Increased fibrinolytic activity, although not the main reason for low fibrinogen, has also been noted shortly after delivery, especially in patients with placental disruption .
• Who: Nándor Ács and collaborators from the Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary Centre for Laboratory Medicine, Haemostasis and Haemophilia Centre, StGallen, Switzerland have published the paper: Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage, in the Journal: (JOURNAL)
• Future: Given the level of evidence available to date further data on the efficacy and safety of rFVIIa . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.